Regulatory News
Tuesday, September 20, 2016
BRIEF-Ampliphi Biosciences provides update on phase 1 trial in chronic rhinosinusitis patients
* Ampliphi Biosciences provides update on phase 1 trial in
chronic rhinosinusitis patients
Read more
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment